NCT02301936 Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT02300558 Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3 Status TERMINATED Phase PHASE3
NCT02300103 Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study Status COMPLETED Phase PHASE2
NCT02296853 Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment Status COMPLETED Phase PHASE1
NCT02295384 Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia Status COMPLETED Phase N/A
NCT02292706 A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection Status TERMINATED Phase N/A
NCT02291237 Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy Status TERMINATED Phase PHASE2/PHASE3
NCT02285114 Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen Status COMPLETED Phase PHASE2/PHASE3
NCT02276612 Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents Status COMPLETED Phase PHASE2/PHASE3
NCT02275065 Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants Status COMPLETED Phase PHASE1
NCT02272062 Patient-Reported Preferences Affecting Revascularization Decisions Status COMPLETED Phase NA
NCT02265796 Ranolazine Among Unrevascularized Chronic Stable Angina Patients Status COMPLETED Phase PHASE2
NCT02258581 Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection Status TERMINATED Phase N/A
NCT02258555 Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma Status TERMINATED Phase PHASE1
NCT02258529 Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma Status TERMINATED Phase PHASE2
NCT02254421 Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract Status COMPLETED Phase PHASE2
NCT02254408 Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract Status COMPLETED Phase PHASE2
NCT02253394 The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study Status TERMINATED Phase PHASE4